Firms collude to manipulate medicine prices
July 11, 2012 | 14:01
Healthcare company GlaxoSmithKline Pte Ltd Singapore (GSK) has been found to have colluded with a local pharmaceutical manufacturer to manipulate medicine prices, with the products eventually coming to customers at prices four to five times higher than their original rates.
Mobile Version